> "I call us the off-label bandits — a title I am proud to bear,” said Dr. Adam Friedman I get the sentiment, but bandits don't go to school for twenty years.

> "I call us the off-label bandits — a title I am proud to bear,” said Dr. Adam Friedman I get the sentiment, but bandits don't go to school for twenty years. Cholestyramine, for example, is a quality of life necessity for some patients following cholecystectomy, but there'll never be widespread acceptance by surgeons since its not their area. > "Oral minoxidil costs pennies a day,” Dr. King said. “There is no incentive to spend tens of millions of dollars to test it in a clinical trial. That study truly is never, ever going to be done.” Just a shame. Can there be no other path to getting acknowledgement from the FDA? More and more I am inclined to ignore their seal (or lack thereof). > Some patients taking low-dose minoxidil, though, notice stray hairs growing on their faces and chins. So some dermatologists, including Dr. Sinclair, have added another drug — very low doses of spironolactone, a blood pressure drug that also blocks certain sex hormones called androgens — to try to prevent unwanted hair growth. To be clear, minoxidil is a vasodilator and spironolactone is a diuretic - both can treat hypertension, but in different ways. At the hair-regrowth dose, I assume these effects are negligible, but I hope the bandits are handy with their sphygmomanometers.